Table 3.
Multivariate Analysis of Clinicopathological Features Associated with Pericolic Lymph Nodes Metastasis beyond 10 cm Proximal to The Tumor
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| pPCN group (n = 14) | nPCN group (n = 298) | P value | OR | 95% CI | P value | |
| cTNM stage n(%) | 0.018 | 11.749 | 2.121–65.081 | 0.005 | ||
| I | 0 (0.0%) | 50 (16.8%) | ||||
| II | 3 (21.4%) | 91 (30.5%) | ||||
| III | 8 (57.2%) | 135 (45.3%) | ||||
| IV | 3 (21.4%) | 22 (7.4%) | ||||
| No. of PCNs | 4.5 (1.0–11.0) | 0 (0–12.0) | < 0.001 | 1.868 | 1.257–2.775 | 0.002 | 
| Total no. of positive mesenteric lymph nodes | 3.5 (1.0–14.0) | 0 (0–11.0) | 0.002 | 5.156 | 2.152–12.356 | < 0.05 | 
| Presence of the largest mesenteric lymph nodes with the maximum short-axis diameter ≥ 8 mm | 7 (50%) | 49 (16.4%) | 0.005 | 5.571 | 0.839–37.0 | 0.075 | 
pPCN group, patients in this group with pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor
nPCN group, patients in this group without pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor
PCNs, pericolic lymph nodes located beyond 10 cm proximal to the tumor
OR odds ratio, CI confidence interval